What is the current Europe, MEA Substance Abuse Treatment Market size?

The Europe, MEA Substance Abuse Treatment Market is projected to register a CAGR of 9% during the forecast period (2024-2029) Read More

Who are the key players in Europe, MEA Substance Abuse Treatment Market?

Mallinckrodt LLC, Indivior PLC, Alkermes PLC, Viatris and GSK plc are the major companies operating in the Europe, MEA Substance Abuse Treatment Market. Read More

What years does this Europe, MEA Substance Abuse Treatment Market cover?

The report covers the Europe, MEA Substance Abuse Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe, MEA Substance Abuse Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe, MEA Substance Abuse Treatment Market Share

Statistics for the 2023 & 2024 Europe, MEA Substance Abuse Treatment market share, created by Mordor Intelligence™ Industry Reports. Europe, MEA Substance Abuse Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Europe, MEA Substance Abuse Treatment Industry

The market is highly competitive and consists of several major players. Companies like Alkermes PLC, Abbvie (Allergan), GSK plc, Mallinckrodt LLC, Viatris, Pfizer Inc., Purdue Pharma LP, Sanofi, and Teva Pharmaceutical Industries Ltd, among others, hold a substantial share in the market studied.